发明名称 COMBINATION THERAPY FOR TREATMENT OF OBESITY AND DIABETES AND CONDITION RELATED THERETO AND FOR TREATMENT OF CONDITION AMELIORATED BY INCREASING BLOOD GLP-1 LEVEL
摘要 <p>PROBLEM TO BE SOLVED: To provide a composition for treating or preventing diabetes or a condition related thereto comprising a therapeutically effective amount of a BRS-3 agonist and a DPP-IV inhibitor.SOLUTION: The invention relates to a combination of a certain amount of a BRS-3 agonist with a certain amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level or in increasing a blood GLP-1 level in a subject over that provided by the certain amount of the BRS-3 agonist alone or by the certain amount of the DPP-IV inhibitor alone, and to the use of such a combination for treating or preventing obesity and diabetes and conditions related thereto and conditions ameliorated by increasing a blood GLP-1 level. The invention also relates to the use of a G protein-coupled receptor to shield for GLP-1 secretagogues.</p>
申请公布号 JP2015120749(A) 申请公布日期 2015.07.02
申请号 JP20150057165 申请日期 2015.03.20
申请人 ARENA PHARMACEUTICALS INC 发明人 CHU ZHI-LIANG;LEONARD JAMES N
分类号 A61K45/06;A61P3/04;A61P3/06;A61P3/10;A61P9/00;A61P9/10;A61P9/12;A61P25/02;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P27/02;A61P27/12;A61P43/00;C12N15/09;C12Q1/02;G01N33/15;G01N33/50 主分类号 A61K45/06
代理机构 代理人
主权项
地址